Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766820

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766820

Italy Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "Italy Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Italy Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The Italy Oncology Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the Italy Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Italy Oncology is segmented as follows -

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The Italy Oncology Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25623CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Oncology Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Oncology Market, Italy

  • 3.1 Oncology Market, Italy, Revenue ($m), 2018-2033
    • 3.1.1 ALK Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.2 BCR-ABL Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.3 BRAF Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.4 BRCA Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.5 Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.6 EGFR Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.7 HER2 Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 3.1.8 KRAS Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
  • 3.2 Oncology Market, Italy, Volume (Units), 2018-2033
    • 3.2.1 ALK Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.2 BCR-ABL Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.3 BRAF Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.4 BRCA Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.5 Colorectal Cancer Screening Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.6 EGFR Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.7 HER2 Tests Market, Italy, Volume (Units), by Segment, 2018-2033
    • 3.2.8 KRAS Tests Market, Italy, Volume (Units), by Segment, 2018-2033
  • 3.3 Oncology Market, Italy, Average Price ($) , 2018-2033
  • 3.4 Oncology Market, Italy, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in Italy, Oncology Market

  • 4.1 F. Hoffmann-La Roche Ltd
    • 4.1.1 Company Overview
  • 4.2 Agilent Technologies Inc
    • 4.2.1 Company Overview
  • 4.3 Qiagen NV
    • 4.3.1 Company Overview
  • 4.4 Abbott Laboratories
    • 4.4.1 Company Overview
  • 4.5 Danaher Corp
    • 4.5.1 Company Overview
  • 4.6 Roche Diagnostics International Ltd
    • 4.6.1 Company Overview
  • 4.7 Eiken Chemical Co Ltd
    • 4.7.1 Company Overview
  • 4.8 Alfresa Pharma Corp
    • 4.8.1 Company Overview
  • 4.9 Amoy Diagnostics Co Ltd
    • 4.9.1 Company Overview
  • 4.10 SENTINEL CH SpA
    • 4.9.1 Company Overview

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

  • 6.1 Partnerships
    • 6.1.1 A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix

7 Recent Developments

  • 7.1 Other Significant Developments
    • 7.1.1 Jan 14, 2025: Enea TECH and Biomedical Foundation invests €15 Million in Tethis to Develop New Diagnostic Methods in Oncology Using Liquid Biopsy
    • 7.1.2 Dec 06, 2024: RayStation in clinical use for proton arc therapy at the Trento Proton Therapy Center
  • 7.2 Product News
    • 7.2.1 Mar 10, 2025: Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk of Survival Events Over Time Between Young BRCA1/2 Carriers
    • 7.2.2 Jan 27, 2025: Ikonisys Secures U.S. Patent for "Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments"
    • 7.2.3 Aug 01, 2024: Development of a Method to Predict Onset of Non-Alcoholic Fatty Liver Disease -Contributing to Preventive Healthcare for Lifestyle Diseases

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer
Product Code: GDME25623CCDB

List of Table

List of Tables

  • Table 1: Oncology Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 2: ALK Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 3: BCR-ABL Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 4: BRAF Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 5: BRCA Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 6: Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 7: EGFR Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 8: HER2 Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 9: KRAS Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Oncology Market, Italy, Volume (Units), 2018-2033
  • Table 11: ALK Tests Market, Italy, Volume (Units), 2018-2033
  • Table 12: BCR-ABL Tests Market, Italy, Volume (Units), 2018-2033
  • Table 13: BRAF Tests Market, Italy, Volume (Units), 2018-2033
  • Table 14: BRCA Tests Market, Italy, Volume (Units), 2018-2033
  • Table 15: Colorectal Cancer Screening Tests Market, Italy, Volume (Units), 2018-2033
  • Table 16: EGFR Tests Market, Italy, Volume (Units), 2018-2033
  • Table 17: HER2 Tests Market, Italy, Volume (Units), 2018-2033
  • Table 18: KRAS Tests Market, Italy, Volume (Units), 2018-2033
  • Table 19: Oncology Market, Italy, Average Price ($), 2018-2033
  • Table 20: Oncology Market, Italy, Company Share by Revenue ($m), 2024
  • Table 21: Oncology Market Pipeline Products
  • Table 22: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
  • Table 23: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Oncology Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: ALK Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: BCR-ABL Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 4: BRAF Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: BRCA Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 6: Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: EGFR Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: HER2 Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: KRAS Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Oncology Market, Italy, Volume (Units), 2018-2033
  • Figure 11: ALK Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 12: BCR-ABL Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 13: BRAF Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 14: BRCA Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 15: Colorectal Cancer Screening Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 16: EGFR Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 17: HER2 Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 18: KRAS Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 19: Oncology Market, Italy, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!